Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$18.86 USD
+0.37 (2.00%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $18.84 -0.02 (-0.11%) 7:12 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
CAPR 18.86 +0.37(2.00%)
Will CAPR be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CAPR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CAPR
What Makes Capricor (CAPR) a Good Fit for 'Trend Investing'
Does Capricor (CAPR) Have the Potential to Rally 90.16% as Wall Street Analysts Expect?
CAPR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Capricor (CAPR) Surges 18.2%: Is This an Indication of Further Gains?
Capricor Therapeutics (CAPR) Reports Q2 Loss, Misses Revenue Estimates
Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings Estimates
Other News for CAPR
CSX Posts Weak Earnings, Joins Lucid Group, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Capricor Therapeutics Announces Major Public Offering
Capricor Therapeutics stock falls after pricing $75M equity offering
Capricor Therapeutics 4.41M Spot Secondary prices at $17.00 per share
10 Health Care Stocks With Whale Alerts In Today's Session